Ceasing to be a substantial holder
Released
Released
Announcement PDF
605
page 1/2 15 July 2001
Form 605
Corporations Act 2001
Section 671B
Notice of ceasing to be a substantial holder
To Company Name/Scheme
Neuren Pharmaceuticals Limited
ACN/ARSN
45 122 593 462
1. Details of substantial holder(1)
Name
Milford Asset Management Limited
ACN/ARSN (if applicable)
The holder ceased to be a
substantial holder on
17 / 07 / 24
The previous notice was given to the company on
The previous notice was dated
02 / 12 / 22
30 / 11 /22
2. Changes in relevant interests
Particulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities of the company or scheme, since the
substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:
Date of
change
Person whose
relevant interest
changed
Nature of
change (4)
Consideration
given in relation
to change(5)
Class (6) and
number of
securities
affected
Person's votes
affected
See below
3. Changes in association
The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the substantial holder in relation to voting
interests in the company or scheme are as follows:
Name and ACN/ARSN (if applicable)
Nature of association
N/A
4. Addresses
The addresses of persons named in this form are as follows:
Name
Address
Milford Asset Management Limited
Level 28, 48 Shortland Street, Auckland, 1010, New Zealand
Signature
print name
sign here
Zachary Kenworthy
capacity
date 19
Team Leader, Operations
/
07
/ 2024
Date of
Change
Persons who's
interest changed
2/12/2022 17/07/2024
Milford Asset
Management Limited
Nature of
Change
Sells for total
consideration
Buys for total
consideration
Units
Consideration
Class
9,003,256 $ 131,556,267.17 Fully Paid Ordinary Shares
8,499,600 $ 132,031,317.82 Fully Paid Ordinary Shares
Share your feedback
Discover